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a b s t r a c t
How the H7N9 avian inﬂuenza virus gained the distinct ability to infect humans is unclear. Pigs are an
important host in inﬂuenza virus ecology because they are susceptible to infection with both avian and
human inﬂuenza viruses and are often involved in interspecies transmission. Here, we passaged one
avian isolate and one human isolate in pigs to examine the mammalian host adaptation of the H7N9
virus. The avian virus replicated to a high titer after one passage, whereas the human isolate replicated
poorly after three passages in pig lungs. Sequence analysis found nine substitutions in the HA, NA, M and
NS segments of the avian isolate, which enhanced the binding afﬁnity for human-type receptors. These
results indicate that avian H7N9 inﬂuenza viruses can be easily adapted to pigs and that pigs may act as
an important intermediate host for the reassortment and transmission of such novel viruses.
& 2014 Elsevier Inc. All rights reserved.
Introduction
In March 2013, a novel avian-origin H7N9 subtype inﬂuenza
virus was recognized as the causative agent of an inﬂuenza-like
illness in humans in eastern China (Gao et al., 2013). Since then, it
has caused more than 130 human infections in China, resulting in
45 deaths (World Health Organization, 2013). More recently, on
October 15, 2013, two new conﬁrmed cases appeared in Zhejiang
Province, China. Most patients presented with respiratory infec-
tions that progressed to severe pneumonia and dyspnea (Gao
et al., 2013). The identiﬁcation of the potential virus source and
possible routes of virus reassortment is currently ongoing. The
majority of patients were reported to have a history of contact
with live poultry (Chen et al., 2013). However, whether H7N9 can
be transmitted from other sources, such as pigs, is unclear.
Pigs are susceptible to infection with avian and human inﬂu-
enza viruses and have been suggested to serve as intermediate
hosts for the generation of pandemic human strains of inﬂuenza
virus (Kida et al., 1988; Webster et al., 1971, 1973; Yasuda et al.,
1991). The potential to generate novel inﬂuenza viruses has
resulted in pigs being labeled as “mixing vessels.” The mixing
vessel theory provides one mechanism by which unique viruses
can be transmitted from an avian reservoir to humans.
To date, no H7N9 infections from the recent outbreak have
been reported in pigs. Surveillance of pig farms in the affected
regions has yielded more than 4000 animal and environmental
samples, all of which have been negative (Centers for Disease
Control and Prevention (CDC), 2013). However, a recent study by
Zhu et al. (2013) demonstrated that a human H7N9 isolate was
able to infect pigs experimentally. Watanabe et al. (2013) also
reported that a mild infection of H7N9 virus with no clinical
symptoms was observed in pigs. The potential of these viruses to
infect pigs and generate additional mammalian adaptations is a
signiﬁcant public health concern. In this study, we passaged one
avian isolate and one human isolate in pigs to further our under-
standing of mammalian host adaptation of the H7N9 virus. Amino
acid sequence alignment shows that there are seven variations in
HA (including Q226L), three variations in NA, and one each in M
and NS between these two original viruses. We believe that our
results will facilitate a better understanding of the role of pigs in
the outbreak and transmission of novel H7N9 viruses.
Results
Consecutive passages of H7N9 viruses in pigs
Successive virus passages were initiated in six naïve 4-week-
old, outbred, speciﬁc pathogen-free Bama minipigs (three pigs for
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each virus) by intranasal inoculation with 106 TCID50 of A/chicken/
Zhejiang/DTID-ZJU01/2013 (CK) or A/Anhui/1/2013 (AH). The pigs
were euthanized 4 days post-inoculation (d.p.i.), and the nasal
swabs that contained viruses with mutations were used for the
next passage inoculation. The results showed that none of the
inoculated pigs developed any clinical signs of infection during the
4-day observation period or had virus-induced lesions upon
necropsy. Virus shedding from the upper respiratory tract started
at 1 d.p.i. for all inoculated pigs, reaching peak titers at 2 or 3 d.p.i.
The virus titers in the nasal and throat swabs were generally
comparable for each individual pig inoculated with the same virus
(P40.05, Supplementary Fig. S1). However, we found that the
nasal and throat swabs and the lung tissues collected from pigs
inoculated with the CK-P1-to-P3 virus had higher titers than those
from animals inoculated with the CK-P0 virus (Po0.05) (Fig. 1(a)).
In contrast, for the human AH virus isolate, the titers from the
nasal and throat swabs and the lung tissues of pigs inoculated with
the AH-P2 or P3 virus were generally lower than those from
animals inoculated with the AH-P0 or P1 virus (Po0.05) (Fig. 1
(b)). Furthermore, by using one-way ANOVA and DUNCAN and LSD
methods analysis, we convinced that throughout the all 4 day
sampling periods of nasal and throat swabs, there were still
signiﬁcant differences between CK-P1-to-P3 virus with CK-P0
virus, and AH-P2 or P3 virus with AH-P0 or P1 virus (Po0.05).
Additionally, histopathological analyses revealed that on 4 d.p.i.,
lung tissues from the pigs inoculated with the CK-P0 or AH-P2-to-P3
virus had focal mild interstitial pneumonia, with alveolar septa
that were slightly broadened (Fig. 2(b, n, and o)). For pigs
inoculated with the CK-P1-to-P3 or AH-P0-to-P1 virus, the lung
tissue lesions were larger, and interstitial inﬂammatory hyperemia
and exudative pathological changes could be observed in parts of
the lungs (Fig. 2(c–e, l, and m)). Immunohistochemistry was also
performed to assess the presence of viral antigens in lung tissues.
In pigs inoculated with the CK-P1-to-P3 or AH-P0-to-P1 virus,
greater numbers of infected cells were detected in the lung tissues
(Fig. 2(h–j, q, and r)) compared with those from pigs inoculated
with the CK-P0 or AH-P2-to-P3 virus (Fig. 2(g, s, and t)).
All the above data indicated that the pathogenicity of the CK
virus increased while the AH virus pathogenicity decreased after
adaptation over four passages in the pig host.
Receptor binding speciﬁcity of the viruses passaged in pigs
We next tested the receptor speciﬁcity of the CK-P0, CK-P3,
AH-P0 and AH-P3 viruses using a solid-phase binding assay.
The results showed that all four viruses could bind to all glycans.
However, the binding afﬁnity of the CK-P3 virus to α2,6 glycans
was signiﬁcantly increased compared with that of CK-P0 (Fig. 3
(a and b)). Notably, compared with AH-P0, which showed a mixed
α2,3 and α2,6 receptor preference, AH-P3 largely bound to α2,3
glycans (Fig. 3(c and d)). We therefore speculated that after three
passages in the pig host, the avian-isolated CK virus and human-
isolated AH virus exhibited increased human-type receptor binding
activity and avian-type receptor binding properties, respectively.
Amino acid substitutions in the viral genomes during
consecutive passages in pigs
The nasal swabs collected from each inoculated pig at 4 d.p.i.
were grown in MDCK cells, and ﬁve plaque-picked viral clones
were obtained and sequenced individually to obtain the H7N9
viral genome sequence. Compared with CK-P0, there were nine
mutations in CK-P1, which were substituted by the amino acids
present in the human-origin virus; no additional mutations
appeared until CK-P3 (Table 1). The nine mutations were identiﬁed
in eight plaque clones from three pig nasal swabs. Six mutations
(Gly63Cys, Pro65Leu, Arg66Leu, and Met67Ile in HA [H3 number-
ing] and Ala436Thr and Gly437Ser in NA) existed simultaneously
in ﬁve plaque clones from one pig nasal swab. The mutations
Gly33Val in HA and Val423Leu in NA existed in two plaque clones
from one pig nasal swab, and the mutation Phe3Ser in NS existed
in one plaque clone from a separate pig nasal swab. All of these
changes were in amino acids identical to those in human-isolated
H7N9 strains. Meanwhile, compared with AH-P0, one mutation
(Leu267Pro in M) appeared in the AH-P1 virus and existed in all
ﬁve plaque clones from one pig nasal swab. In the AH-P2 viruses,
two more mutations appeared: Arg56Lys in HA, which existed in
four plaque clones from one pig nasal swab, and Leu226Gln in HA,
which existed in all ﬁve plaque clones from another pig nasal swab
(Tables 1 and 2). All three changes were in amino acids identical to
those in avian-isolated H7N9 strains. The sequences of all above-
mentioned mutated viral genes were deposited in GenBank under
accession numbers KF768178-KF768182.
Discussion
Avian H7N9 inﬂuenza virus may be introduced into humans by
direct transmission or through an intermediate host susceptible to
both human and avian viruses. Pigs are susceptible to infection
with both avian and human inﬂuenza viruses and are thought to
play an important role in human inﬂuenza ecology. Pigs are the
only domesticated mammalian species that is reared in abundance
and is susceptible to and allows the productive replication of avian
and human inﬂuenza viruses. This susceptibility is due to the
presence of both α2,3 and α2,6 galactose–sialic acid linkages in
cells lining the pig trachea, which can result in the modiﬁcation of
the receptor-binding speciﬁcities of avian inﬂuenza viruses from
α2,3 linkages to α2,6 linkages (Ito et al., 1998). This latter linkage is
the native linkage in humans, thereby providing a potential link
from birds to humans. Although Chan et al. (2013) found that there
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Fig. 1. Viral titers from nasal and throat swabs and from lung tissue. Successive viral passages were initiated in six naïve pigs (three pigs for each virus) by intranasal
inoculation with 2 ml of allantoic ﬂuid containing 106 TCID50 of A/Anhui/1/2013 (AH) or A/chicken/Zhejiang/DTID-ZJU01/2013 (CK). Nasal and throat swabs were collected
daily. The pigs were euthanized at 4 d.p.i., and the lung tissues were collected. Virus replication in the nasal and throat swabs taken at 4 d.p.i. was compared. The geometric
mean titers are displayed, and the error bars indicate standard deviation. nPo0.05.
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was not as much expression of α2,3 glycans on the surface of the
trachea of pigs. Infection of α2,3 binding avian viruses was
restricted to the lower respiratory tract bronchioles, which may
diminish the ability of the swine to act as an intermediary in the
transmission of avian viruses to humans. However, Jones et al.
(2013) assessed the replication ability of three human H7N9
viruses (A/Anhui/1/2013, A/Shanghai/1/2013, A/Shanghai/2/2013)
in swine tissue explants, and viruses tested replicated efﬁciently in
tracheas and bronchi of the explants, with limited replication in
alveolar cells.
This study demonstrated that H7N9 viruses isolated from
an avian species and a human were capable of infecting pigs.
However, the avian virus was able to replicate to a high titer after
one passage, whereas the human isolate replicated poorly after
three passages in pig lungs. In the avian isolate, sequence analysis
found nine substitutions that led to enhanced binding afﬁnity for
IHC
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Fig. 2. Histopathological and immunohistochemical (IHC) analyses of the lung tissues of pigs inoculated with wild-type or passaged H7N9 inﬂuenza viruses. (b–e): H–E
staining results of the lung tissues of pigs inoculated with the P0–P3 CK viruses; 100. (i–o): H–E staining results of the lung tissues of pigs inoculated with the P0–P3 AH
viruses; 100. (g–j); immunohistochemical results of the lung tissues of pigs inoculated with the P0–P3 AH viruses; 400. (q–t): immunohistochemical results of the lung
tissues of pigs inoculated with the P0–P3 AH viruses; 400.
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Fig. 3. Direct binding assay of wild-type and passaged H7N9 inﬂuenza viruses with synthetic sialylglycopolymers. (a) Afﬁnity for synthetic 30SLN. (b) Afﬁnity for synthetic
30S-DI-LN. (c) Afﬁnity for synthetic 60SLN. (d) Afﬁnity for synthetic 60S-DI-LN.
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human-type receptors. Except for Met67Ile in HA, which has not
been reported previously, the observed mutations were found to
exist in a number of H7N9 viruses in GenBank, with most identiﬁed
in human isolates. A series of recombinant viruses should be
constructed by reverse genetics to determine whether any of these
substitutions are critical to receptor binding speciﬁcity.
It is unknown why the human H7N9 isolated virus, after succes-
sive passages in pigs, a mammalian host, developed enhanced afﬁnity
for avian-type receptors, but the H7N9 virus appears to not be well
adapted to its new mammalian host species. We observed three
substitutions in the human H7N9 isolate during three adaption
passages in pigs. All three mutations were found to exist in a number
of H7N9 viruses in GenBank, in isolates either from human patients or
avian species. Notably, the Leu226Gln substitution in the HA protein
was identiﬁed after two passages of the human-origin virus in pigs
and was accompanied by a decrease in virus titer in the pig lungs and
enhanced binding afﬁnity for avian-type receptors. The Leu226Gln
substitution has long been recognized to modulate receptor binding
speciﬁcity from α2,6 to α2,3 galactose-sialic acid receptors (Herfst
et al., 2012; Imai et al., 2012). Previous serosurveillance studies have
indicated that the prevailing human viruses of both H1N1 and H3N2
subtypes are transmitted to pigs, but fail to persist (Brown, 2000).
It is not clear why these viruses fail to persist in pigs, but since
immune selection is not considered important in pigs, strains with
different antigenic characteristics may be disadvantaged compared to
the ‘highly-adapted’ established viruses which continually circulate
within a large susceptible population (Brown, 2000).
We also observed that there were genome polymorphisms of
plaque-picked virus clones from each passage in each individual
animal. Some mutations existed in all ﬁve plaque clones of one
inoculated pig while others appeared only in one virus clone. This
may reﬂex the virus evolution preference when adapted to a new
mammalian host.
As avian H7N9 inﬂuenza viruses can be easily adapted to pigs,
the infection of pigs with avian-isolated H7N9 strains should be
recognized to result in viruses gaining adaptations necessary to
either maintain infection in pigs, thereby providing a reservoir for
human infection, or allow transmission to humans, leading to the
establishment of this virus in the human population (Londt et al.,
2012). Therefore, H7N9 inﬂuenza virus genes could potentially be
introduced to humans via pigs. To date, there is little evidence of
the human-to-human transmission of H7N9. However, the poten-
tial circulation of this virus in pigs may result in critical changes
that alter its pathogenicity or transmission potential.
Materials and methods
Viruses
The A/Anhui/1/2013 (H7N9) virus (AH-P0) was isolated from
the third case of laboratory-conﬁrmed human A (H7N9) virus
infection. The patient was a 35-year-old woman who had visited a
chicken market 1 week before the onset of symptoms. A throat
swab was collected from the patient, propagated in the allantoic
Table 1
Amino acid mutations in passaged CK and AH viral genomes.
Virus Passage number Amino acid position
HA NA M NS
33 56 63 65 66 67 226 423 436 437 267 3
CK P0 Gly Lys Gly Pro Arg Met Gln Val Ala Gly Pro Phe
P1 Val Lys Cys Leu Leu Ile Gln Leu Thr Ser Pro Ser
P2 Val Lys Cys Leu Leu Ile Gln Leu Thr Ser Pro Ser
P3 Val Lys Cys Leu Leu Ile Gln Leu Thr Ser Pro Ser
AH P0 Val Arg Cys Leu Leu Ile Leu Leu Thr Ser Leu Ser
P1 Val Arg Cys Leu Leu Ile Leu Leu Thr Ser Pro Ser
P2 Val Lys Cys Leu Leu Ile Gln Leu Thr Ser Pro Ser
P3 Val Lys Cys Leu Leu Ile Gln Leu Thr Ser Pro Ser
Note: Abbreviation: CK, A/chicken/Zhejiang/DTID-ZJU01/2013 (H7N9) virus; AH, A/Anhui/1/2013 (H7N9) virus; HA, hemagglutinin protein; NA, neuraminidase protein;
M, matrix protein; NS, non-structural protein.
The mutations during the adaption process are underlined in bold.
GenBank accession numbers: CK-P0-HA: KC899669.1; CK-P0-NA: KC899671.1; CK-P0-NS: KC899673.1; CK-P1-to-P3-HA: KF768178; CK-P1-to-P3-NA: KF768179; CK-P1-to-P3-
NS: KF768180; AH-P2-to-P3-HA: KF768181; AH-P2-to-P3-M: KF768182.
GISAID accession number: AH-P0-HA: EPI439507; AH-P0-M: EPI439506.
Table 2
Distribution of mutations in each passage and each individual animal.
Viruses Passage Pig no. Total plaque clones
from each pig
Plaque clone with
mutations
Mutation amounts Mutations
CK P1 1 5 5 (100%) 6 Gly63Cys, Pro65Leu, Arg66Leu, Met67Ile in HA;
Ala436Thr, Gly437Ser in NA
2 5 2 (40%) 2 Gly33Val in HA; Val423Leu in NA
3 5 1 (20%) 1 Phe3Ser in NS
AH P1 1 5 5 (100%) 1 Leu267Pro in M
2 5 0 (0%) 0 /
3 5 0 (0%) 0 /
P2 1 5 4 (80%) 1 Arg56Lys in HA
2 5 5 (100%) 1 Leu226Gln in HA
3 5 0 (0%) 0 /
Note: Abbreviation: CK, A/chicken/Zhejiang/DTID-ZJU01/2013 (H7N9) virus; AH, A/Anhui/1/2013 (H7N9) virus; HA, hemagglutinin protein; NA, neuraminidase protein;
M, matrix protein; NS, non-structural protein.
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sacs and amniotic cavities of 9 to 11 day old embryonated chicken
eggs and then passaged once in Madin–Darby canine kidney
(MDCK) cells. Substitution Q226L (H3 numbering) in the 210-
loop of the HA gene was found in this virus. This site has been
previously shown to change the receptor binding of avian-origin
viruses to human-type receptors and may increase the airborne
transmission ability of the virus. The virus also encoded PB2-627K,
an amino acid essential for the efﬁcient replication of avian
inﬂuenza viruses in mammals. The accession numbers of genome
of A/Anhui/1/2013 (H7N9) virus (AH-P0) virus in GISAID database
are EPI439503 to EPI439503.
A/chicken/Zhejiang/DTID-ZJU01/2013 (H7N9) virus (CK-P0) was
isolated from fecal samples taken from a chicken in a poultry market
in Zhejiang Province in April 2013. This virus was also propagated
in the allantoic sacs and amniotic cavities of 9 to 11 day old
embryonated chicken eggs and then passaged once in MDCK cells.
No molecular markers for human-type receptor binding properties
were identiﬁed in the viral genome. The accession numbers
of genome of A/chicken/Zhejiang/DTID-ZJU01/2013 (H7N9) virus
(CK-P0) virus in Genbank are KC899666 to KC899673.
Cells
MDCK cells were obtained from the ATCC and were tested for
mycoplasma contamination. The cells were maintained in Eagle's
minimal essential medium (MEM, Invitrogen, USA) supplemented
with 10% fetal bovine serum (FBS), 100 IU/ml penicillin and
100 μg/ml of streptomycin and were cultured at 37 1C with 5% CO2.
Successive passages of H7N9 viruses in pigs
Four-week-old outbred speciﬁc pathogen-free Bama minipigs
were kept in self-contained isolator units in an ABSL-3 facility. Prior
to virus inoculation, the serum samples were evaluated for anti-
bodies against currently circulating human and swine inﬂuenza
viruses using hemagglutination-inhibition (HI) tests. Successive viral
passages were initiated in six naïve pigs (three pigs per virus) by
intranasal inoculation with 1 ml of allantoic ﬂuid containing 106
TCID50 of AH-P0 or ZJ-P0. Nasal and throat swabs were collected
daily and transferred to 1 ml of phosphate-buffered saline (PBS).
Virus titers were determined by end-point titration in MDCK cells.
The pigs were euthanized with a mixture of anesthetics (25 mg/kg
ketamine, 2 mg/kg xylazine and 0.05 mg/kg atropine) 4 d.p.i., and the
lung tissues were collected for pathological and virological studies.
The nasal swabs collected from each inoculated pig at 4 d.p.i. were
grown in MDCK cells, and ﬁve plaque-picked viral clones were
obtained and sequenced individually to obtain the H7N9 viral
genome sequence, and specimens with mutations were used for
the next passage. The inoculation titer used was 106 TCID50 for both
viruses. If mutations existed in more than one sample, each nasal
swab was mixed equally and intranasally re-inoculated into the three
naïve pigs. Virus passaging was repeated three times. The experi-
mental protocol was evaluated and approved by the Institutional
Animal Use and Care Committee of the Institute of Laboratory Animal
Science, Peking Union Medical College (ILAS-PC-2013-009). All pigs
were allocated randomly to experimental groups and processed. All
experiments were performed under ABSL-3 conditions.
Virus titrations
Virus titrations were performed by end-point titration in MDCK
cells. The MDCK cells were inoculated with tenfold serial dilutions
of homogenized tissue and nasal and throat swabs. One hour after
inoculation, the cells were washed once with PBS and grown in
200 μl of infection media, which consisted of MEM supplemented
with 100 U/ml penicillin, 100 μg/ml streptomycin and 1 μg/ml
TPCK-trypsin. At 3 d.p.i., the supernatants of infected cell cultures
were tested for agglutinating activity using turkey erythrocytes as
an indicator of cellular infection. Infectious titers were calculated
from ﬁve replicates by the Reed and Muench method (Reed and
Muench, 1938).
HI assays
Standard HI assays were performed on pig sera using 0.5%
turkey erythrocytes in accordance with the WHO guidelines for
established procedures (World Health Organization—Global inﬂuenza
surveillance network, 2011). Sera were collected from pigs and tested
for H7N9 virus-speciﬁc antibodies.
Histopathology and immunohistochemistry
Animal necropsies were performed according to a standard
protocol. Samples for histological examination were stored in 10%
neutral-buffered formalin (lungs after inﬂation with formalin),
embedded in parafﬁn and sectioned at 4 μm. The sections were
stained with hematoxylin and eosin (H–E) for examination by light
microscopy or using an immunohistochemical method with a
monoclonal antibody against the nucleoprotein of inﬂuenza A
virus (1:200 dilution, IRR Ltd, Catalog no.: FR-51) at 4 1C overnight.
The sections were washed three times with PBS and then incu-
bated with HRP-conjugated goat anti-mouse secondary antibody
(1:5000 dilution, Sigma, Catalog no.: PV-9002). The sections were
developed with 3-30 diaminobenzidine (DAB) and examined with
a light microscope.
Genome sequencing
For sequencing, a total of 198 primer sets were used to amplify
the full genome with the Qiagen OneStep RT-PCR Kit. The PCR
products were puriﬁed from an agarose gel using the QIAquick Gel
Extraction Kit (Qiagen, Germany). We performed sequencing using
an ABI 3730xl automatic DNA analyzer (Life Technologies, USA) and
the ABI BigDye Terminator v3.1 cycle sequencing kit (Life Technolo-
gies, USA) according to the manufacturer's recommendations.
Solid-phase binding assay
Synthetic Neu5Acα2-3Galβ1-4GlcNAcβ-Sp (30SLN), Neu5Acα-
2-3[Galβ1-4GlcNAcβ1-3]2β-Sp (30S-Di-LN), Neu5Acα2-6Galβ1-
4GlcNAcβ-Sp (60SLN) and Neu5Acα2-6[Galβ1-4GlcNAcβ1-3]2β-Sp
(60S-Di-LN) were obtained through the resource request program
of the Consortium of Functional Glycomics. Flat-bottom, polystyr-
ene, 96-well plates were incubated with sialylglycopolymers in
PBS at 4 1C overnight. The glycopolymer solution was then
removed, and the plates were blocked with 0.15 ml of PBS
containing 4% BSA at room temperature for 1 h. After four
successive washes with ice-cold PBS, the plates were incubated
with a solution containing the virus (32 HAU) at 4 1C overnight.
The plates were then washed as described above and incubated for
2 h at 4 1C with a monoclonal antibody against the inﬂuenza A
virus nucleoprotein (1:1000 dilution, IRR Ltd., Catalog no. FR-51).
The plates were washed as before and incubated with horseradish
peroxidase (HRP)-conjugated goat-anti-mouse IgG antisera for 2 h
at 4 1C. After another wash step, the plates were incubated with
tetramethylbenzidine substrate solution, and the absorbance at
450 nm was measured.
Statistical analysis
Statistical analysis of the differences in the virus titers were
performed by SPSS 11.5 software, and the DUNCAN and LSD
L. Xu et al. / Virology 452-453 (2014) 231–236 235
methods were used for detection in one-way ANOVA means.
A probability value o0.05 was considered statistically signiﬁcant.
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